Acticor raises €1.7mm through undisclosed round

15:40 EDT 30 Oct 2018 | Elsevier Business Intelligence

Acticor Biotech SAS (mAb therapeutics to treat ischemic stroke) completed a €1.7mm ($2mm) undisclosed round from Primer Cap...

Original Article: Acticor raises €1.7mm through undisclosed round


More From BioPortfolio on "Acticor raises €1.7mm through undisclosed round"

Quick Search


Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Stroke - Cerebrovascular Disease (CVA)
A stroke is a serious medical condition that occurs when the blood supply to part of the brain is cut off. Strokes are a medical emergency and prompt treatment is essential because the sooner a person receives treatment for a stroke, the less damage is ...